美国风湿病学会对风湿与肌肉骨骼疾病患者COVID-19疫苗接种的指导(第3版)
美国风湿病学会组建包括风湿病学家、感染病专家和公共卫生医师的工作组,基于文献和公开数据,采用改良德尔菲法和RAND/UCLA适宜性方法,就风湿与肌肉骨骼疾病患者COVID-19疫苗接种及围接种期免疫调节治疗的使用和时机达成74条共识指导陈述。
要点
- 工作组就RMD患者COVID-19疫苗接种及围接种期免疫调节治疗形成74条共识指导陈述。
- 共识基于有限直接证据,采用改良德尔菲法和RAND/UCLA适宜性方法制定。
- 指导旨在帮助风湿科医生优化RMD患者COVID-19疫苗接种策略。
核心结论
- 在临床数据有限背景下,工作组达成74条共识指导陈述,为RMD患者COVID-19疫苗使用及围接种期免疫调节治疗提供方向。
研究设计与样本
- 工作组包括9名风湿病学家/免疫学家、2名感染病专家和2名公共卫生医师,采用改良德尔菲法和RAND/UCLA适宜性方法经2轮会议迭代达成共识。
主要发现
- 尽管直接证据匮乏,工作组制定并共识通过了74条指导陈述,涵盖RMD患者COVID-19疫苗使用及围接种期免疫调节治疗的使用和时机。
关键数值与推荐
- 共识采用9分数字评分系统评估对草案陈述的同意程度,共识基于评分分布确定。
临床怎么用
- 指导风湿科医疗提供者最佳使用COVID-19疫苗,并促进RMD患者疫苗接种策略的实施。
局限性
- 指导陈述基于有限的临床数据制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). METHODS: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings. RESULTS: Despite a paucity of direct evidence, 74 draft guidance statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination. CONCLUSION: These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
引用
- Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3. Arthritis Rheumatol. 2021. PMID: 34346564. doi:10.1002/art.41928
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。